Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma

The objective of this prospective study was to identify baseline angiogenic and inflammatory markers in serum as well as the baseline levels of immune cells in whole blood to predict progression‐free survival in patients with metastatic renal cell carcinoma treated with sunitinib. Blood samples were...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Ryuichi, Kimura, Go, Fukasawa, Satoshi, Ueda, Takeshi, Kondo, Tsunenori, Hara, Hidehiko, Shoji, Sunao, Kanao, Kent, Nakazawa, Hayakazu, Tanabe, Kazunari, Horie, Shigeo, Oya, Mototsugu, Yuasa, T., Horiguchi, A., Nakaigawa, N., Oyama, M., Nagata, H., Ishida, M., Kawata, N., Hatano, T., Kishida, T., Morita, J., Yamaguchi, R., Nakagawa, T., Kume, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581523/
https://www.ncbi.nlm.nih.gov/pubmed/28699300
http://dx.doi.org/10.1111/cas.13320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581523/
https://www.ncbi.nlm.nih.gov/pubmed/28699300
http://dx.doi.org/10.1111/cas.13320

Ejemplares similares